Making real world evidence fit for purposeAlthough real world evidence (RWE) is a hot topic in pharma right now, many still question whether it Share XMaking real world evidence fit for purposehttps://pharmaphorum.com/views-analysis-market-access/making-real-world-evidence-fit-for-purpose/
Nine pharma trends for 2020Sarah Rickwood looks back at how pharma changed over the last decade and what this might mean for Share XNine pharma trends for 2020https://pharmaphorum.com/views-analysis-digital/nine-pharma-trends-for-2020/
Real-world or real evidence?There was a time when the distinction between data from clinical trials and data from any other source Share XReal-world or real evidence?https://pharmaphorum.com/r-d/views-analysis-r-d/real-world-or-real-evidence/
Demonstrating the value of RWEA new cross-industry effort hopes to research the benefits of RWE and promote acceptance of alternatives to traditional Share XDemonstrating the value of RWEhttps://pharmaphorum.com/views-analysis-oncology/demonstrating-the-value-of-rwe/
Real world evidence, digital partnerships and the future of pharmaAhead of the eyeforpharma Awards we spoke to judge Jennifer Wong – AstraZeneca’s senior director, RWE strategy & Share XReal world evidence, digital partnerships and the future of pharmahttps://pharmaphorum.com/views-analysis-digital/real-world-evidence-digital-partnerships-and-the-future-of-pharma/
Transforming oncology with a pan-European approach to data sharingBetween genomic data, electronic health records and digital health tools, we have all the information we need to Share XTransforming oncology with a pan-European approach to data sharinghttps://pharmaphorum.com/views-analysis-oncology/transforming-oncology-with-a-pan-european-approach-to-data-sharing/
Nine for 2019: Opportunities for pharmaIn the last Nine for 2019 article, we reflected on the major challenges that are shaping the pharmaceutical Share XNine for 2019: Opportunities for pharmahttps://pharmaphorum.com/views-and-analysis/nine-for-2019-opportunities-for-pharma/
Janssen announces first data centres for haematology networkJanssen has announced the first two data centres to join its HONEUR (Haematology Outcomes Network in Europe) collaborative Share XJanssen announces first data centres for haematology networkhttps://pharmaphorum.com/news/janssen-announces-first-data-centres-for-haematology-network/
Harnessing RWE in rare diseasesAhead of eyeforpharma Philadelphia 2019, Sonal Bhatia, Pfizer’s vice president, North America medical lead, rare disease talked to Share XHarnessing RWE in rare diseaseshttps://pharmaphorum.com/r-d/views-analysis-r-d/harnessing-rwe-in-rare-diseases/
